Publications by authors named "S Cernic"
Experience in donation after circulatory-determined death (DCD) heart transplantation (HTx) is expanding. There is limited information on the functional outcomes of DCD HTx recipients. We sought to evaluate functional outcomes in our cohort of DCD recipients.
View Article and Find Full Text PDFBackground: Lung cancer represents a heterogeneous group of neoplasms, with the highest frequency and mortality in both sexes combined. In a clinical scenario characterized by the widespread of multidetector-row spiral CT, core-needle biopsy under tomographic guidance is one of the main and safest methods to obtain tissue specimens, even though there are relatively high rates of pneumothorax (0-60% incidence) and pulmonary hemorrhage (4-27% occurrence rates). The aim of this retrospective study is to assess the diagnostic accuracy of CT-guided core-needle biopsy in the diagnosis of primary lung malignancies and to compare our results with evidence from the literature.
View Article and Find Full Text PDFArticle Synopsis
- The study evaluates the effectiveness and safety of Percutaneous Cryoablation (PCA) for small renal masses (SRMs) in patients unsuitable for surgery, analyzing data from four centers over a 10-year period.
- Patients were categorized based on the size of their masses into two groups, with results indicating a significantly higher success rate (Trifecta outcomes) in smaller masses compared to larger ones, and a notable increase in complications for the larger group.
- Overall, PCA shows promise as a safe and effective treatment, but suggests that stricter size limits may improve success rates for managing SRMs.
Background: Ex-situ heart perfusion (ESHP) is commonly used for the reanimation and preservation of hearts following donation after circulatory determined death (DCD). The only commercially available existing ESHP device promotes perfusate lactate levels for assessment of heart viability. The reliability of this marker is yet to be confirmed for DCD heart transplantation.
View Article and Find Full Text PDFCryoablation is emerging as a safe and effective therapeutic option for treating renal cell carcinoma. This study analyzed the safety and long-term oncological outcomes of cryoablation in our center. Patients who underwent computed tomography (CT)-guided percutaneous cryoablation between February 2011 and June 2020 for one or more clinically localized renal tumors were identified.
View Article and Find Full Text PDF